Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

Fine-scale damage estimates of particulate matter air pollution reveal opportunities for location-specific mitigation of emissions.

Goodkind AL, Tessum CW, Coggins JS, Hill JD, Marshall JD.

Proc Natl Acad Sci U S A. 2019 Apr 30;116(18):8775-8780. doi: 10.1073/pnas.1816102116. Epub 2019 Apr 8.

2.

Identification and Optimization of Novel Small c-Abl Kinase Activators Using Fragment and HTS Methodologies.

Simpson GL, Bertrand SM, Borthwick JA, Campobasso N, Chabanet J, Chen S, Coggins J, Cottom J, Christensen SB, Dawson HC, Evans HL, Hobbs AN, Hong X, Mangatt B, Munoz-Muriedas J, Oliff A, Qin D, Scott-Stevens P, Ward P, Washio Y, Yang J, Young RJ.

J Med Chem. 2019 Feb 28;62(4):2154-2171. doi: 10.1021/acs.jmedchem.8b01872. Epub 2019 Feb 11.

PMID:
30689376
3.

Global estimates of mortality associated with long-term exposure to outdoor fine particulate matter.

Burnett R, Chen H, Szyszkowicz M, Fann N, Hubbell B, Pope CA 3rd, Apte JS, Brauer M, Cohen A, Weichenthal S, Coggins J, Di Q, Brunekreef B, Frostad J, Lim SS, Kan H, Walker KD, Thurston GD, Hayes RB, Lim CC, Turner MC, Jerrett M, Krewski D, Gapstur SM, Diver WR, Ostro B, Goldberg D, Crouse DL, Martin RV, Peters P, Pinault L, Tjepkema M, van Donkelaar A, Villeneuve PJ, Miller AB, Yin P, Zhou M, Wang L, Janssen NAH, Marra M, Atkinson RW, Tsang H, Quoc Thach T, Cannon JB, Allen RT, Hart JE, Laden F, Cesaroni G, Forastiere F, Weinmayr G, Jaensch A, Nagel G, Concin H, Spadaro JV.

Proc Natl Acad Sci U S A. 2018 Sep 18;115(38):9592-9597. doi: 10.1073/pnas.1803222115. Epub 2018 Sep 4.

4.

Optimizing the revenue cycle to promote growth of the pharmacy enterprise.

O'Neal BC, Friemel AM, Glowczewski JE, Coggins JM, Macchia M, Forrey RA, Patel KR, Granko RP.

Am J Health Syst Pharm. 2018 Jun 15;75(12):853-855. doi: 10.2146/ajhp170335. No abstract available.

PMID:
29880521
5.

Cumulative incidence, risk factors, and management of atrial fibrillation in patients receiving ibrutinib.

Wiczer TE, Levine LB, Brumbaugh J, Coggins J, Zhao Q, Ruppert AS, Rogers K, McCoy A, Mousa L, Guha A, Heerema NA, Maddocks K, Christian B, Andritsos LA, Jaglowski S, Devine S, Baiocchi R, Woyach J, Jones J, Grever M, Blum KA, Byrd JC, Awan FT.

Blood Adv. 2017 Sep 8;1(20):1739-1748. doi: 10.1182/bloodadvances.2017009720. eCollection 2017 Sep 12.

6.

Blue Skies Bluer?

Marshall JD, Apte JS, Coggins JS, Goodkind AL.

Environ Sci Technol. 2015 Dec 15;49(24):13929-36. doi: 10.1021/acs.est.5b03154. Epub 2015 Nov 23.

PMID:
26535809
7.

Simple SNP-based minimal marker genotyping for Humulus lupulus L. identification and variety validation.

Henning JA, Coggins J, Peterson M.

BMC Res Notes. 2015 Oct 6;8:542. doi: 10.1186/s13104-015-1492-2.

8.

Health benefits of air pollution abatement policy: Role of the shape of the concentration-response function.

Pope CA 3rd, Cropper M, Coggins J, Cohen A.

J Air Waste Manag Assoc. 2015 May;65(5):516-22. doi: 10.1080/10962247.2014.993004.

PMID:
25947311
9.

Caring for the dying---lessons learnt in New Zealand.

Coggins J.

Nurs N Z. 2012 May;18(4):30-1. No abstract available.

PMID:
22866470
10.

A qualitative exploration of emotional inhibition: a basic emotions and developmental perspective.

Coggins J, Fox JR.

Clin Psychol Psychother. 2009 Jan-Feb;16(1):55-76. doi: 10.1002/cpp.604.

PMID:
19161207
11.
12.

Nanomolar competitive inhibitors of Mycobacterium tuberculosis and Streptomyces coelicolor type II dehydroquinase.

Prazeres VF, Sánchez-Sixto C, Castedo L, Lamb H, Hawkins AR, Riboldi-Tunnicliffe A, Coggins JR, Lapthorn AJ, González-Bello C.

ChemMedChem. 2007 Feb;2(2):194-207.

PMID:
17245805
13.

Crystal structures of Helicobacter pylori type II dehydroquinase inhibitor complexes: new directions for inhibitor design.

Robinson DA, Stewart KA, Price NC, Chalk PA, Coggins JR, Lapthorn AJ.

J Med Chem. 2006 Feb 23;49(4):1282-90.

PMID:
16480265
14.

Rational design of new bifunctional inhibitors of type II dehydroquinase.

Toscano MD, Stewart KA, Coggins JR, Lapthorn AJ, Abell C.

Org Biomol Chem. 2005 Sep 7;3(17):3102-4. Epub 2005 Aug 1.

PMID:
16106291
15.

Strengthening midwifery leadership.

Coggins J.

RCM Midwives. 2005 Jul;8(7):310-3. Review. No abstract available.

PMID:
16035436
16.

Identification of 4-amino-4-deoxychorismate synthase as the molecular target for the antimicrobial action of (6s)-6-fluoroshikimate.

Bulloch EM, Jones MA, Parker EJ, Osborne AP, Stephens E, Davies GM, Coggins JR, Abell C.

J Am Chem Soc. 2004 Aug 18;126(32):9912-3.

PMID:
15303852
17.

Crystallization and preliminary X-ray crystallographic analysis of shikimate kinase from Erwinia chrysanthemi.

Krell T, Coyle JE, Horsburgh MJ, Coggins JR, Lapthorn AJ.

Acta Crystallogr D Biol Crystallogr. 1997 Sep 1;53(Pt 5):612-4.

PMID:
15299895
18.

(1R,4S,5R)-3-Fluoro-1,4,5-trihydroxy-2-cyclohexene-1-carboxylic acid: the fluoro analogue of the enolate intermediate in the reaction catalyzed by type II dehydroquinases.

Frederickson M, Roszak AW, Coggins JR, Lapthorn AJ, Abell C.

Org Biomol Chem. 2004 Jun 7;2(11):1592-6. Epub 2004 May 6.

PMID:
15162210
19.

The structure of Escherichia coli ATP-phosphoribosyltransferase: identification of substrate binding sites and mode of AMP inhibition.

Lohkamp B, McDermott G, Campbell SA, Coggins JR, Lapthorn AJ.

J Mol Biol. 2004 Feb 6;336(1):131-44.

PMID:
14741209
20.

A complete shikimate pathway in Toxoplasma gondii: an ancient eukaryotic innovation.

Campbell SA, Richards TA, Mui EJ, Samuel BU, Coggins JR, McLeod R, Roberts CW.

Int J Parasitol. 2004 Jan;34(1):5-13.

PMID:
14711585
21.

Parallel solid-phase synthesis and evaluation of inhibitors of Streptomyces coelicolor type II dehydroquinase.

González-Bello C, Lence E, Toscano MD, Castedo L, Coggins JR, Abell C.

J Med Chem. 2003 Dec 18;46(26):5735-44.

PMID:
14667226
22.

Enzymic synthesis of 3-[3- 13C]dehydroquinic acid.

Frederickson M, Parker EJ, Coggins JR, Abell C.

Org Biomol Chem. 2003 Oct 7;1(19):3271-3.

PMID:
14584789
24.

Design, synthesis and evaluation of bifunctional inhibitors of type II dehydroquinase.

Toscano MD, Frederickson M, Evans DP, Coggins JR, Abell C, González-Bello C.

Org Biomol Chem. 2003 Jun 21;1(12):2075-83.

PMID:
12945898
25.

Experiences with the shikimate-pathway enzymes as targets for rational drug design.

Coggins JR, Abell C, Evans LB, Frederickson M, Robinson DA, Roszak AW, Lapthorn AP.

Biochem Soc Trans. 2003 Jun;31(Pt 3):548-52. Review.

PMID:
12773154
26.

Twists and turns: a tale of two shikimate-pathway enzymes.

Brown KA, Carpenter EP, Watson KA, Coggins JR, Hawkins AR, Koch MH, Svergun DI.

Biochem Soc Trans. 2003 Jun;31(Pt 3):543-7. Review.

PMID:
12773153
27.

Effects of salts on the function and conformational stability of shikimate kinase.

Cerasoli E, Kelly SM, Coggins JR, Lapthorn AJ, Clarke DT, Price NC.

Biochim Biophys Acta. 2003 May 30;1648(1-2):43-54.

PMID:
12758146
28.

Structures of shikimate dehydrogenase AroE and its Paralog YdiB. A common structural framework for different activities.

Michel G, Roszak AW, Sauvé V, Maclean J, Matte A, Coggins JR, Cygler M, Lapthorn AJ.

J Biol Chem. 2003 May 23;278(21):19463-72. Epub 2003 Mar 12.

29.

Early pregnancy care. Part 2.

Coggins J.

Pract Midwife. 2003 Jan;6(1):24-6. Review. No abstract available.

PMID:
12611398
30.

Early pregnancy care. Part 1.

Coggins J.

Pract Midwife. 2002 Oct;5(9):14-7. Review.

PMID:
12400408
31.

Specificity of substrate recognition by type II dehydroquinases as revealed by binding of polyanions.

Evans LD, Roszak AW, Noble LJ, Robinson DA, Chalk PA, Matthews JL, Coggins JR, Price NC, Lapthorn AJ.

FEBS Lett. 2002 Oct 23;530(1-3):24-30.

32.

Vinyl fluoride as an isoelectronic replacement for an enolate anion: inhibition of type II dehydroquinases.

Frederickson M, Coggins JR, Abell C.

Chem Commun (Camb). 2002 Sep 7;(17):1886-7.

PMID:
12271658
34.

Kinetic analysis of the interaction between the QutA and QutR transcription-regulating proteins.

Watts C, Si-Hoe SM, Lamb HK, Levett LJ, Coggins JR, Hawkins AR.

Proteins. 2002 Aug 1;48(2):161-8.

PMID:
12112685
36.

The refolding of type II shikimate kinase from Erwinia chrysanthemi after denaturation in urea.

Cerasoli E, Kelly SM, Coggins JR, Boam DJ, Clarke DT, Price NC.

Eur J Biochem. 2002 Apr;269(8):2124-32.

37.

The structure and mechanism of the type II dehydroquinase from Streptomyces coelicolor.

Roszak AW, Robinson DA, Krell T, Hunter IS, Fredrickson M, Abell C, Coggins JR, Lapthorn AJ.

Structure. 2002 Apr;10(4):493-503.

38.

The shikimate pathway and its branches in apicomplexan parasites.

Roberts CW, Roberts F, Lyons RE, Kirisits MJ, Mui EJ, Finnerty J, Johnson JJ, Ferguson DJ, Coggins JR, Krell T, Coombs GH, Milhous WK, Kyle DE, Tzipori S, Barnwell J, Dame JB, Carlton J, McLeod R.

J Infect Dis. 2002 Feb 15;185 Suppl 1:S25-36. Review.

PMID:
11865437
39.

Selective Inhibition of Type II Dehydroquinases.

Frederickson M, Parker EJ, Hawkins AR, Coggins JR, Abell C.

J Org Chem. 1999 Apr 16;64(8):2612-2613. No abstract available.

PMID:
11674325
40.

Derailing Dehydroquinate Synthase by Introducing a Stabilizing Stereoelectronic Effect in a Reaction Intermediate.

Parker EJ, Coggins JR, Abell C.

J Org Chem. 1997 Nov 28;62(24):8582-8585. No abstract available.

PMID:
11672011
41.

Biochemical and X-ray crystallographic studies on shikimate kinase: the important structural role of the P-loop lysine.

Krell T, Maclean J, Boam DJ, Cooper A, Resmini M, Brocklehurst K, Kelly SM, Price NC, Lapthorn AJ, Coggins JR.

Protein Sci. 2001 Jun;10(6):1137-49.

42.

Purification, crystallization and preliminary X-ray crystallographic analysis of ATP-phosphoribosyltransferase from Escherichia coli.

Lohkamp B, Coggins JR, Lapthorn AJ.

Acta Crystallogr D Biol Crystallogr. 2000 Nov;56(Pt 11):1488-91.

PMID:
11185885
43.

Identification of domains responsible for signal recognition and transduction within the QUTR transcription repressor protein.

Levett LJ, Si-Hoe SM, Liddle S, Wheeler K, Smith D, Lamb HK, Newton GH, Coggins JR, Hawkins AR.

Biochem J. 2000 Aug 15;350 Pt 1:189-97.

44.

Irreversible inhibition of type I dehydroquinase by substrates for type II dehydroquinase.

Bello CG, Harris JM, Manthey MK, Coggins JR, Abell C.

Bioorg Med Chem Lett. 2000 Mar 6;10(5):407-9.

PMID:
10743936
45.

Crystallization and preliminary X-ray analysis of shikimate dehydrogenase from Escherichia coli.

Maclean J, Campbell SA, Pollock K, Chackrewarthy S, Coggins JR, Lapthorn AJ.

Acta Crystallogr D Biol Crystallogr. 2000 Apr;56(Pt 4):512-5.

PMID:
10739937
46.

Mechanistic studies on type I and type II dehydroquinase with (6R)- and (6S)-6-fluoro-3-dehydroquinic acids.

Parker EJ, González Bello C, Coggins JR, Hawkins AR, Abell C.

Bioorg Med Chem Lett. 2000 Feb 7;10(3):231-4.

PMID:
10698442
47.

The two types of 3-dehydroquinase have distinct structures but catalyze the same overall reaction.

Gourley DG, Shrive AK, Polikarpov I, Krell T, Coggins JR, Hawkins AR, Isaacs NW, Sawyer L.

Nat Struct Biol. 1999 Jun;6(6):521-5.

PMID:
10360352
48.

The folding and assembly of the dodecameric type II dehydroquinases.

Price NC, Boam DJ, Kelly SM, Duncan D, Krell T, Gourley DG, Coggins JR, Virden R, Hawkins AR.

Biochem J. 1999 Feb 15;338 ( Pt 1):195-202.

49.

Evidence for the shikimate pathway in apicomplexan parasites.

Roberts F, Roberts CW, Johnson JJ, Kyle DE, Krell T, Coggins JR, Coombs GH, Milhous WK, Tzipori S, Ferguson DJ, Chakrabarti D, McLeod R.

Nature. 1998 Jun 25;393(6687):801-5. Erratum in: Nature 1998 Sep 17;395(6699):801.

PMID:
9655396
50.

The three-dimensional structure of shikimate kinase.

Krell T, Coggins JR, Lapthorn AJ.

J Mol Biol. 1998 May 22;278(5):983-97.

PMID:
9600856

Supplemental Content

Loading ...
Support Center